// App-Quantinova.ai

SAT0281 : BIOSAMPLES FROM AT RISK SSC PATIENTS SHOW CLASSIC PATHOLOGICAL SIGNS OF SCLERODERMA: OPPORTUNITY FOR DIAGNOSIS OF PRE-CLINICAL SSC

Researchers

Presenter

  • R. Ross

Principal Investigators

  • I. Georgiou

  • A. Carriero

  • G. Abignano

  • C. Wasson

  • G. Migneco

  • A. Herrick

  • C. Denton

  • F. Del Galdo

Medical Centers

  • University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine and Biomedical Research Centre, Leeds, United Kingdom

  • San Carlo Hospital of Potenza, Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, Lucania, Italy

  • The University of Manchester, Division of Musculoskeletal & Dermatological Sciences (L5) Division of Musculoskeletal & Dermatological Sciences, Manchester, United Kingdom

  • University College of London, Centre for Rheumatology, Division of Medicine, London, United Kingdom

  • Chapel Allerton Hospital, NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Caveolin 1

  • Cluster of Differentiation 31

  • C-X-C motif chemokine ligand 9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GSK plc

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved